Work

Exploring the Role of Glycosylation Inhibitors in Lymphoma and Drug Therapy

Year: 2024

Type: article

Abstract: Objective: Lymphoma, impacting individuals across all age groups with a preference for younger males, presents challenges in drug target selectivity. Mucin glycosylation is being investigated as a potential cellular barrier in the treatment of lymphoma. This review explores glycosylation inhibitors as potential enhancers of therapeutic agents for lymphoma treatment.

Source: American Journal of Pharmaceutical Education

DOI: 10.1016/j.ajpe.2024.101215

Authors: Shayan Mosaffa, Nasr Issa, Thao Nguyen, Robert Campbell

Institution: Massachusetts College of Pharmacy and Health Sciences

Language: English

Topic: Glycosylation and Glycoproteins Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,400